Of note, in the context of HIV infection, a recent study identified CD57+NKG2C+ NK cells as the predominant ADCC effector subset capable of targeting HIV-infected CD4+ T cells in the presence of broadly neutralizing antibodies (38, 59). The gene discussed is B3GAT1; the disease is HIV infectious disease.